TScan Therapeutics Statistics
NASDAQ: TCRXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.238+0.0098 (+4.29%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
TScan Therapeutics by the numbers
TScan Therapeutics has a market capitalization of $16.1 million based on 63.50M shares outstanding. With trailing EPS of $-0.91, TScan Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 55.7% below its 50-day average and 74.1% below its 200-day average.
Average daily trading volume is 783.59K shares, or about $186,494 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TCRX valuation vs. peer median
| Metric | TCRX | Peer median | Difference |
|---|---|---|---|
| Market cap | $16.13M | $14.48M | +11% |
| Avg. volume | 783.59K | 48.49K | +1516% |
Peer median across 8 companies: BCDA, DYAI, ESLA, JSPR, INAB, PLUR, PASG, INTS.
Valuation
- Market cap
- $16.13M
- EPS (TTM)
- $-0.91
- Shares outstanding
- 63.50M
Price and trading
- Previous close
- 0.2282
- Open
- 0.2282
- Day range
- 0.2279 – 0.2474
- 52-week range
- 0.224 – 2.57
- 52-week change
- -88.47%
- 50-day moving average
- 0.5368
- 200-day moving average
- 0.9205
- Beta
- —
- Volume
- 869.28K
- Average volume
- 783.59K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2025
Additional statistics
- Market Cap
- 16.13M
- Forward Pe
- -0.42
- Eps
- -0.91
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.57
- Week52 Low
- 0.22
- Avg Volume
- 783.59K
- Shares Outstanding
- 63.50M
- Ma50
- 0.54
- Ma200
- 0.92
- Earnings Date
- Nov 12, 2025
- Pct From52w High
- -90.74%
- Pct From52w Low
- 6.25%